C0003153479P
This role serves as a scientific and technical leader advancing machine learning-enabled molecular design across the drug discovery portfolio. The position involves defining and delivering models, platforms, and strategies to shorten design-make-test-analyze cycles and improve molecule quality. As a hands-on strategic leader, the individual will set a multi-year technical roadmap and lead a team of approximately 25 scientists and engineers. The role requires deep fluency in contemporary machine learning combined with a practical understanding of medicinal chemistry, structural biology, and drug discovery realities.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for C0003153479P.
5% above the average for this role
Senior Principal Research Scientist, Computational Chemistry
IDEAYA Biosciences, Inc.
Computational Chemistry Scientist
Roche
Senior Director, AIRx Computational Chemistry
Takeda Pharmaceutical Company Limited
Senior Scientist II (Computational Chemistry)
Exelixis
Principal / Senior Principal Scientist, Computational Chemistry
Antares Therapeutics
Principal CADD Scientist
Genesis Molecular AI